“Then people would be pre-primed with antibodies so that when the parasites emerged into their bloodstream the immune system would be there ready to stop them invading red blood cells", said Dr. Julian Rayner, while explaining about a latest research claiming to lead the development of a high caliber vaccine against the disease.

In addition, the expert has insisted that developing a vaccine against malaria will surely play a significant role in combating the disease, and marked it as simplest and most effective measure to prevent people against malaria.

As per available data, more than 50% global population can be considered to have an increased risk for developing the health condition. People living in poor developing countries are more likely to die from it. Figures retrieved from the World Health Organization database have suggested more than 225 million annual cases of malaria along with 800,000 deaths where sub-Saharan African regions have contributed enough to increase the figure.

A team of enthusiastic experts at the Wellcome Trust's Sanger Institute are attempting to explore attributes of a parasite plasmodium Falciparum, that is already know to have a key role to communicate the disease as well as to kill the red blood cells in human blood. Night-biting mosquitoes serve as an active source for its spread.

Prior to this, Mosquirix developed an experimental vaccine Mosquirix against malaria after receiving handsome donation from the Gates Foundation. It is in ultimate stages of clinical testing and has already been observed around 50% efficient, during the early trails.

Inspite of tremendous medical advancement, Malaria, a mosquito-borne disease is still killing countless people all over the world, especially in regions with feasible climatic conditions for mosquito population. Experts are putting their hard efforts to develop some effective vaccination against the deadly disease and to reduce the related death rate.